We noticed you’re blocking ads

Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Innovations | Jul 2014

RETeval Visual Visualectrodiagnostic Device


The RETeval Visual Electrodiagnostic Device measures the 30-Hz flicker electroretinogram, which reportedly has a strong correlation to retinal ischemic diseases such as diabetic retinopathy, is used in the monitoring of vigabatrin toxicity, and can be used to distinguish between ischemic and nonischemic central retinal vein occlusion.

RETeval is a handheld screening device that uses skin electrodes, enabling virtually any health care provider to screen a patient in just a few minutes. No dilation is required regardless of pupillary size or the presence of a cataract.

Advertisement - Issue Continues Below
Publication Ad Publication Ad
End of Advertisement - Issue Continues Below